Nov 05, 2020 / 01:45PM GMT
Operator
Ladies and gentlemen, thank you for standing by and welcome to Arbutus Biopharma Corporation 2020 Third Quarter Financial Results and Corporate Update. (Operators Instruction]. As a reminder, this conference is being recorded. I would now like to hand the conference over to Pam Murphy, you may begin.
Pam Murphy - Arbutus Biopharma Corporation - IR Consultant
Good morning and thank you for joining Arbutus' Third Quarter 2020 Conference Call. On the call today are William Collier, President and Chief Executive Officer; Dr. Mike Sofia, Chief Scientific Officer; Dr. Gaston Picchio, Chief Development Officer and Dave Hastings, Chief Financial Officer.
Bill will begin with a summary of recent accomplishments and upcoming events and a review of Arbutus' corporate objectives followed by Dave Hastings who will provide a quick recap of Arbutus' key third-quarter financial results. We'll then open the call for Q&A. Before we begin, we'd like to remind you that some of the statements made during the call today are forward-looking statements, including
Q3 2020 Arbutus Biopharma Corp Earnings Call Transcript
Nov 05, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers